Development of sustainable processes for pharmaceutical R&D

被引：0
|
作者：
Wheelhouse, Katherine [1 ]
机构：
[1] GSK, Stevenage, Herts, England
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 253卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
70
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Will genomics revolutionise pharmaceutical R&D?
    Noble, D
    [J]. TRENDS IN BIOTECHNOLOGY, 2003, 21 (08) : 333 - 337
  • [22] Pharmaceutical R&D: an age of change?
    Baldwin, John J.
    [J]. FUTURE MEDICINAL CHEMISTRY, 2014, 6 (10) : 1109 - 1112
  • [23] R&D EFFECTIVENESS IN THE PHARMACEUTICAL INDUSTRY
    Konopielko, Lukasz
    Trehubova, Anastasiia
    [J]. ECONOMIC AND SOCIAL DEVELOPMENT (ESD 2018): 33RD INTERNATIONAL SCIENTIFIC CONFERENCE ON ECONOMIC AND SOCIAL DEVELOPMENT "MANAGERIAL ISSUES IN MODERN BUSINESS", 2018, : 287 - 296
  • [24] Leading R&D in the pharmaceutical industry
    Scolnick, EM
    [J]. RESEARCH-TECHNOLOGY MANAGEMENT, 2000, 43 (03) : 35 - 38
  • [25] The impact of mergers on pharmaceutical R&D
    John L. LaMattina
    [J]. Nature Reviews Drug Discovery, 2011, 10 : 559 - 560
  • [26] MANAGING RISK IN PHARMACEUTICAL R&D
    Case, Randolph H.
    [J]. RESEARCH-TECHNOLOGY MANAGEMENT, 2010, 53 (02) : 24 - 32
  • [27] The changing shape of pharmaceutical R&D
    Nicolaides, D
    [J]. CHEMICAL INNOVATION, 2001, 31 (11): : 40 - 46
  • [28] R&D in the Global Pharmaceutical Markets
    Kermani, Faiz
    Wollowitz, Susan
    [J]. FUTURE OF THE CHEMICAL INDUSTRY, 2009, 1026 : 19 - 45
  • [29] The impact of mergers on pharmaceutical R&D
    LaMattina, John L.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (08) : 559 - 560
  • [30] The productivity crisis in pharmaceutical R&D
    Fabio Pammolli
    Laura Magazzini
    Massimo Riccaboni
    [J]. Nature Reviews Drug Discovery, 2011, 10 : 428 - 438
12345